• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与新推出的 SARS-CoV-2 疫苗(Comirnaty®)接种相关的死亡。

Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty®).

机构信息

Institute of Legal Medicine, University Medical Center Hamburg-Eppendorf, Butenfeld 34, 22529 Hamburg, Germany.

Institute of Legal Medicine, University Medical Center Hamburg-Eppendorf, Butenfeld 34, 22529 Hamburg, Germany.

出版信息

Leg Med (Tokyo). 2021 Jul;51:101895. doi: 10.1016/j.legalmed.2021.101895. Epub 2021 Apr 17.

DOI:10.1016/j.legalmed.2021.101895
PMID:33895650
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8052499/
Abstract

Since 27th December 2020, a mRNA vaccine from BioNTech / Pfizer (Comirnaty®) has been used across Germany. As of 12th March 2021, 286 fatalities of vaccinated German individuals were registered at the Paul-Ehrlich-Institute with time intervals after vaccination between one hour to 40 days. From our catchment area in northern Germany, we have so far become aware of 22 deaths in connection with vaccination in a 5 week period (range: 0-28 days after vaccination). Three death cases after vaccination with Comirnaty®, which were autopsied at the Institute of Legal Medicine Hamburg, are presented in more detail. All three deceased had severe cardiovascular diseases, among other comorbidities, and died in the context of these pre-existing conditions, while one case developed a COVID-19 pneumonia as cause of death. Taking into account the results of the postmortem examination a causal relation between the vaccination and the death was not established in any case. If there are indications of an allergic reaction, histological and postmortem laboratory examinations should be performed subsequent to the autopsy (tryptase, total IgE, CRP, interleukin-6, complement activity C3/C5).

摘要

自 2020 年 12 月 27 日以来,德国一直在使用来自 BioNTech / Pfizer(辉瑞)的 mRNA 疫苗。截至 2021 年 3 月 12 日,Paul-Ehrlich 研究所登记了 286 名接种后死亡的德国个体,接种后时间间隔从 1 小时到 40 天不等。在我们位于德国北部的服务区内,我们在 5 周内(接种后 0-28 天)已发现 22 例与疫苗接种相关的死亡病例。在汉堡法医研究所对辉瑞疫苗接种后死亡的 3 例病例进行了更详细的尸检。所有三名死者都有严重的心血管疾病,还有其他合并症,并死于这些先前存在的疾病,而一例病例因 COVID-19 肺炎而死亡。考虑到尸检结果,在任何情况下都未发现疫苗接种与死亡之间存在因果关系。如果存在过敏反应的迹象,应在尸检后进行组织学和死后实验室检查(类胰蛋白酶、总 IgE、CRP、白细胞介素-6、补体活性 C3/C5)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f79/8052499/c57ee97f11f6/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f79/8052499/6892572c3ea9/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f79/8052499/260a9b1d889b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f79/8052499/cfb77a85231e/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f79/8052499/c57ee97f11f6/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f79/8052499/6892572c3ea9/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f79/8052499/260a9b1d889b/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f79/8052499/cfb77a85231e/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f79/8052499/c57ee97f11f6/gr4_lrg.jpg

相似文献

1
Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty®).与新推出的 SARS-CoV-2 疫苗(Comirnaty®)接种相关的死亡。
Leg Med (Tokyo). 2021 Jul;51:101895. doi: 10.1016/j.legalmed.2021.101895. Epub 2021 Apr 17.
2
Postmortem investigation of fatalities following vaccination with COVID-19 vaccines.接种 COVID-19 疫苗后的死亡病例的尸检调查。
Int J Legal Med. 2021 Nov;135(6):2335-2345. doi: 10.1007/s00414-021-02706-9. Epub 2021 Sep 30.
3
Dying with SARS-CoV-2 infection-an autopsy study of the first consecutive 80 cases in Hamburg, Germany.死于 SARS-CoV-2 感染——德国汉堡首例连续 80 例尸检研究。
Int J Legal Med. 2020 Jul;134(4):1275-1284. doi: 10.1007/s00414-020-02317-w. Epub 2020 Jun 4.
4
Prospective postmortem evaluation of 735 consecutive SARS-CoV-2-associated death cases.735 例连续 SARS-CoV-2 相关死亡病例的前瞻性尸检评估。
Sci Rep. 2021 Sep 29;11(1):19342. doi: 10.1038/s41598-021-98499-3.
5
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.辉瑞/生物科技和牛津/阿斯利康疫苗对沙特阿拉伯全国疫苗接种运动中真实环境下 COVID-19 发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
6
[Investigation of Humoral and Cellular Immunity in TOBB ETÜ Hospital Workers After Three Doses of CoronaVac Vaccination and after One Dose of Comirnaty Vaccination Following Two Doses of CoronaVac].[对接种三剂科兴疫苗后以及在两剂科兴疫苗基础上接种一剂辉瑞疫苗的TOBB ETÜ医院工作人员的体液免疫和细胞免疫进行调查]
Mikrobiyol Bul. 2022 Jul;56(3):387-403. doi: 10.5578/mb.20229702.
7
Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.分析新加坡成年人接种 2 剂 mRNA COVID-19 或灭活 SARS-CoV-2 疫苗以及接种加强针后的 COVID-19 发病率和严重程度。
JAMA Netw Open. 2022 Aug 1;5(8):e2228900. doi: 10.1001/jamanetworkopen.2022.28900.
8
[Current state of vaccination against SARS-CoV-2].[新型冠状病毒2型(SARS-CoV-2)疫苗接种的现状]
Z Rheumatol. 2021 Mar;80(2):158-164. doi: 10.1007/s00393-021-00966-9. Epub 2021 Feb 2.
9
Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine-a case report.Status migrainosus:一种潜在的辉瑞/ BioNtech(BNT162b2)COVID-19 疫苗不良反应-病例报告。
Neurol Sci. 2022 Feb;43(2):767-770. doi: 10.1007/s10072-021-05741-x. Epub 2021 Nov 22.
10
COVID-19 vaccination including 198 patients with history of severe anaphylactic reaction - own observations.COVID-19 疫苗接种,包括 198 例有严重过敏反应史的患者 - 自身观察。
Przegl Epidemiol. 2021;75(3):315-325. doi: 10.32394/pe.75.28.

引用本文的文献

1
Death from COVID-19 in a Fully Vaccinated Subject: A Complete Autopsy Report.一名全程接种疫苗的受试者因新冠病毒疾病死亡:一份完整的尸检报告。
Vaccines (Basel). 2023 Jan 9;11(1):142. doi: 10.3390/vaccines11010142.
2
A postmortem study of patients vaccinated for SARS-CoV-2 in Colombia.哥伦比亚接受 SARS-CoV-2 疫苗接种患者的尸检研究。
Rev Esp Patol. 2023 Jan-Mar;56(1):4-9. doi: 10.1016/j.patol.2022.09.003. Epub 2022 Oct 31.
3
Mandatory vaccinations, the segregation of citizens, and the promotion of inequality in the modern democracy of Greece and other democratic countries in the era of COVID-19.

本文引用的文献

1
Maintaining Safety with SARS-CoV-2 Vaccines.通过新冠病毒疫苗维持安全性。
N Engl J Med. 2021 Feb 18;384(7):643-649. doi: 10.1056/NEJMra2035343. Epub 2020 Dec 30.
2
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.BNT162b2 mRNA 新冠病毒疫苗的安全性和有效性。
N Engl J Med. 2020 Dec 31;383(27):2603-2615. doi: 10.1056/NEJMoa2034577. Epub 2020 Dec 10.
3
Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals.抗聚乙二醇抗体:性质、形成、检测以及在聚乙二醇化纳米生物制药的不良反应中的作用。
强制性疫苗接种、公民隔离以及在 COVID-19 时代的希腊和其他民主国家的现代民主中促进不平等。
Hist Philos Life Sci. 2022 Dec 7;44(4):72. doi: 10.1007/s40656-022-00548-1.
4
A multi-population-based genomic analysis uncovers unique haplotype variants and crucial mutant genes in SARS-CoV-2.一项基于多群体的基因组分析揭示了新冠病毒中独特的单倍型变异和关键突变基因。
J Genet Eng Biotechnol. 2022 Nov 1;20(1):149. doi: 10.1186/s43141-022-00431-3.
5
Link between COVID-19 vaccines and myocardial infarction.2019冠状病毒病疫苗与心肌梗死之间的关联。
World J Clin Cases. 2022 Oct 6;10(28):10109-10119. doi: 10.12998/wjcc.v10.i28.10109.
6
A systemic review and recommendation for an autopsy approach to death followed the COVID 19 vaccination.一项针对 COVID-19 疫苗接种后死亡的尸检方法的系统回顾和建议。
Forensic Sci Int. 2022 Nov;340:111469. doi: 10.1016/j.forsciint.2022.111469. Epub 2022 Sep 20.
7
Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?临床心血管急症与 COVID-19 疫苗接种的细胞基础:从梦想变为现实?
Int J Infect Dis. 2022 Nov;124:1-10. doi: 10.1016/j.ijid.2022.08.026. Epub 2022 Sep 6.
8
Autopsy findings of post-COVID-19 vaccination deaths in Tokyo Metropolis, Japan, 2021.日本东京都 2021 年 COVID-19 疫苗接种后死亡的尸检结果。
Leg Med (Tokyo). 2022 Nov;59:102134. doi: 10.1016/j.legalmed.2022.102134. Epub 2022 Aug 20.
9
Myocardial Infarction Following COVID-19 Vaccine Administration: ?接种 COVID-19 疫苗后发生心肌梗死:?
Viruses. 2022 Jul 27;14(8):1644. doi: 10.3390/v14081644.
10
Current Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknowns.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)信使核糖核酸(mRNA)疫苗及接种后不良报告的当前证据:已知与未知
Diagnostics (Basel). 2022 Jun 26;12(7):1555. doi: 10.3390/diagnostics12071555.
Adv Drug Deliv Rev. 2020;154-155:163-175. doi: 10.1016/j.addr.2020.07.024. Epub 2020 Aug 1.
4
Post mortem tryptase: A review of literature on its use, sampling and interpretation in the investigation of fatal anaphylaxis.死后组织胰蛋白酶:对其在致死性过敏反应调查中的应用、采样和解释的文献综述。
Forensic Sci Int. 2020 Sep;314:110415. doi: 10.1016/j.forsciint.2020.110415. Epub 2020 Jul 18.
5
The effects of different sampling techniques on peripheral post mortem tryptase levels: a recommended sampling method.不同采样技术对死后外周组织胰蛋白酶水平的影响:一种推荐的采样方法。
Int J Legal Med. 2019 Sep;133(5):1477-1483. doi: 10.1007/s00414-019-02038-9. Epub 2019 Mar 16.
6
Post-mortem in situ stability of serum markers of cerebral damage and acute phase response.脑损伤血清标志物和急性期反应的尸检原位稳定性
Int J Legal Med. 2019 May;133(3):871-881. doi: 10.1007/s00414-018-1925-2. Epub 2018 Aug 30.
7
Intra-individual alterations of serum markers routinely used in forensic pathology depending on increasing post-mortem interval.个体血清标志物在法医病理学中的常规应用随死后时间的延长而发生变化。
Sci Rep. 2018 Aug 24;8(1):12811. doi: 10.1038/s41598-018-31252-5.
8
Anaphylaxis at autopsy.尸检时的过敏反应。
Forensic Sci Med Pathol. 2017 Sep;13(3):269-271. doi: 10.1007/s12024-016-9799-4. Epub 2016 Aug 29.
9
Postmortem diagnosis of fatal anaphylaxis during intravenous administration of therapeutic and diagnostic agents: evaluation of clinical laboratory parameters and immunohistochemistry in three cases.静脉注射治疗和诊断药物期间致命性过敏反应的尸检诊断:三例临床实验室参数及免疫组织化学评估
Leg Med (Tokyo). 2008 May;10(3):143-7. doi: 10.1016/j.legalmed.2007.10.002. Epub 2007 Nov 26.